This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) inched 0.15% higher to $19.43 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.85% to 10,564.52 and the Dow Jones Industrial Average rising 1.31% to 32,827.00. The stock's rise snapped a five-day losing streak. Novavax Inc. closed $217.07 below its 52-week high ($236.50), which the company reached on December 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Replimune Group Inc. (REPL) fell 4.96% to $17.62, VBI Vaccines Inc. (VBIV) rose 2.25% to $0.65, and AnaptysBio Inc. (ANAB) fell 1.95% to $29.09. Trading volume (4.0 M) remained 1.0 million below its 50-day average volume of 5.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 7, 2022.
(END) Dow Jones Newswires
November 07, 2022 17:14 ET (22:14 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.